In the current study, we examined the in vivo function of the STE20-type protein kinase MST4 in systemic metabolic impairment and MASLD progression based on the phenotypic characterization of global and liver-specific Mst4 knockout mice challenged with a high-fat or an MCD diet, respectively. The gene discussed is STK26; the disease is metabolic dysfunction-associated steatotic liver disease.